Blogs
An Ounce of Longevity
5 mins to read
28
November
23
What If Metabolism Didn’t Have to Drop?
Our VP of Global Policy and Strategic Initiatives, Adrienne Hallett explores the vast potential impact of ATX-304, a drug being developed by our PipeCo Amplifier Therapeutics. ATX-304 is a peripherally restricted pan-AMPK activator with the potential to aid in weight loss and maybe even improve cardiac health by increasing metabolism.
See More
Visit
.svg)
An Ounce of Longevity
5 mins to read
22
June
23
If an ounce of prevention is worth a pound of cure, what is longevity worth?
Our VP of Global Policy and Strategic Initiatives, Adrienne Hallett introduces our latest blog segment "An Ounce of Longevity" where she will explore the policy implications of healthy longevity medicines. In her first segment, she shares what healthy aging means to her and highlights the implications for families, communities, societies, and economies.
See More
Visit
Keep up with Cambrian!
Subscribe to receive alerts about our latest blog posts, press releases, and newsletters. Don't worry, you can always manage these preferences later to ensure you receive the updates that interest you the most.
Subscribe to receive alerts about our latest blog posts, press releases, and newsletters. Don't worry, you can always manage these preferences later, or sign up here for specific updates, to ensure you receive the updates that interest you the most.
By clicking subscribe, you are agreeing to our privacy policy.